NCT00298415View on ClinicalTrials.gov

Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

PHASE3CompletedINTERVENTIONAL
Enrollment

451

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

September 30, 2010

Study Completion Date

December 31, 2011

Conditions
NSCLC
Interventions
DRUG

Paclitaxel + Carboplatin

Paclitaxel 90 mg/m² D1, D8, D15 (D1=D29, 4 cycles) Carboplatin AUC 6 D1 (D1=D29, 4 cycles)

DRUG

Monotherapy (gemcitabine or vinorelbine)

Gemcitabine 1150 mg/m² D1 and D8 (D1=D22, 5 cycles) Vinorelbine 30 mg/m² D1 and D8 (D1=22, 5 cycles)

Trial Locations (5)

14000

CHU - Pneumologie, Caen

25000

CHU Besancon - Pneumologie, Besançon

75020

Hôpital Tenon - Pneumologie, Paris

90000

CH - Pneumologie, Belfort

Unknown

CHU, Grenoble

All Listed Sponsors
lead

Intergroupe Francophone de Cancerologie Thoracique

OTHER

NCT00298415 - Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter